🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the effects of sustained-release oral dalfampridine in...
Status
Unknown
Location
Multiple Sclerosis Center
Start Date
2014-11
Trial ID
NCT02259361
Treatments Being Tested
The primary objective is to determine whether prolonged-release fampridine ...
Status
Completed
Location
Research site
Start Date
2014-09
Trial ID
NCT02219932
Treatments Being Tested
This is a global pregnancy registry to evaluate the outcomes of pregnancy i...
Status
Terminated
Location
Hopital Pitie Salpetriere
Start Date
2015-08
Trial ID
NCT01532154
Treatments Being Tested
The objective of the present investigator-initiated mono-center trial to be...
Status
Unknown
Location
University Hospital Zurich, Division of Neurology
Start Date
2012-03
Trial ID
NCT01576354
Treatments Being Tested
This is a multicenter study conducted in 3 parts. Part A is a double-blind ...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01917019
Treatments Being Tested
Prolonged-release fampridine (SR-fampridine) can improving walking capacity...
Status
Completed
Location
Sydvestjysk Sygehus
Start Date
2014-05
Trial ID
NCT02143167
Treatments Being Tested
Spinocerebellar ataxias 27B (SCA27B) is caused by an expansion of ≥ 250 GAA...
Status
Recruiting
Location
Neurology Department, CHU d'Angers
Start Date
2025-10-21
Trial ID
NCT07185347
Treatments Being Tested
The objectives of this study in Multiple Sclerosis (MS) participants treate...
Status
Completed
Location
Research Site
Start Date
2012-08
Trial ID
NCT01597297
Treatments Being Tested
The primary objective of the study is to determine the Pharmacokinetic (PK)...
Status
Completed
Location
Research Site
Start Date
2010-10
Trial ID
NCT01215084
Treatments Being Tested
Phase 4, single center, double-blind, placebo-controlled study. Fifty (50) ...
Status
Completed
Location
Clinique Neuro-Outaouais
Start Date
2013-12
Trial ID
NCT02146534
Treatments Being Tested